Cocrystal Pharma (COCP) Cash from Discontinued Operations (2012 - 2013)

Cocrystal Pharma (COCP) reported Cash from Discontinued Operations of 2506309.0 for Q4 2013, down 320.39% on a YoY basis from 1137226.0 in Q4 2012, and down 320.39% sequentially from 1137226.0 in Q4 2012.

Cocrystal Pharma (COCP) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends

Cocrystal Pharma (COCP) has 2 years of Cash from Discontinued Operations data on file, last reported at 2506309.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Cocrystal Pharma 12.57 Mn 7.74 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2013 -2.51 Mn
Dec 31, 2013 -2.51 Mn
Dec 31, 2012 1.14 Mn
Dec 31, 2012 1.14 Mn